2015
DOI: 10.1016/j.jprot.2015.05.037
|View full text |Cite
|
Sign up to set email alerts
|

Quantitative proteomic analysis of paired colorectal cancer and non-tumorigenic tissues reveals signature proteins and perturbed pathways involved in CRC progression and metastasis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
23
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 35 publications
(25 citation statements)
references
References 91 publications
2
23
0
Order By: Relevance
“…Proteomic studies of CRC have been conducted using surgically resected tissues to develop biomarkers and identify drug targets2627. However, the reliable quantification of the changes in tumor proteome and the interpretation of a large proteomic data set remain challenging.…”
Section: Discussionmentioning
confidence: 99%
“…Proteomic studies of CRC have been conducted using surgically resected tissues to develop biomarkers and identify drug targets2627. However, the reliable quantification of the changes in tumor proteome and the interpretation of a large proteomic data set remain challenging.…”
Section: Discussionmentioning
confidence: 99%
“…Fisher's exact test was used to account for the sample pairing using the protein analysis program Scaffold Q+ version 4.4.3. A fold-change cut-off of 1.5 and a P-value cut-off of 0.05, as used by various quantitative proteomic studies (19)(20)(21)(22), were used as minimum criteria for differential protein expression. The construction of the interaction pathways between the differentially-expressed proteins was generated by Integrated System Interactome (24).…”
Section: Analysis Of Dius By Nano-lc-quadrupole-time-of-flight (Nlc-qmentioning
confidence: 99%
“…For example, Di Palma et al [43] applied FACS analysis to sort a limited number of colon stem cells extracted from mouse intestine which led to the identification of 1085 proteins. A recent proteomic analysis [46] of paired colorectal cancer and adjacent normal tissues from CRC patients identified 948 proteins in total, of which 184 proteins were differentially expressed (P<0.05, fold change >1.5) between tumor and non-tumor tissues. Among these proteins, cancer associated proteins such as FN1, TNC, DEFA1 and ITGB2 were found upregulated [46].…”
Section: Resultsmentioning
confidence: 99%
“…A recent proteomic analysis [46] of paired colorectal cancer and adjacent normal tissues from CRC patients identified 948 proteins in total, of which 184 proteins were differentially expressed (P<0.05, fold change >1.5) between tumor and non-tumor tissues. Among these proteins, cancer associated proteins such as FN1, TNC, DEFA1 and ITGB2 were found upregulated [46]. Using a proteomic analysis of minute amounts of colonic biopsies by enteroscopy sampling, Liu et al identified 2620 proteins between cancer mucosa and adjacent normal colorectal mucosa, of which 195 proteins were differentially upregulated in cancer tissues [47].…”
Section: Resultsmentioning
confidence: 99%